IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 440 
Small font sizeDefault font sizeIncrease font size
Navigate Here
    Next article
    Previous article
    Table of Contents

Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7685    
    Printed198    
    Emailed16    
    PDF Downloaded1568    
    Comments [Add]    
    Cited by others 5    

Recommend this journal

 

 SHORT COMMUNICATION
Year : 2009  |  Volume : 41  |  Issue : 4  |  Page : 197-198

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes


Department of Pharmacology, AIMSR, Bhatinda, India

Correspondence Address:
Rajiv Mahajan
Department of Pharmacology, AIMSR, Bhatinda
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.56070

Rights and Permissions








[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow